212 related articles for article (PubMed ID: 12469192)
1. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone.
Shoieb AM; Elgayyar M; Dudrick PS; Bell JL; Tithof PK
Int J Oncol; 2003 Jan; 22(1):107-13. PubMed ID: 12469192
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
Ng WK; Yazan LS; Ismail M
Toxicol In Vitro; 2011 Oct; 25(7):1392-8. PubMed ID: 21609759
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.
Sutton KM; Greenshields AL; Hoskin DW
Nutr Cancer; 2014; 66(3):408-18. PubMed ID: 24579801
[TBL] [Abstract][Full Text] [Related]
4. In vitro reversal of glutathione-S-transferase-mediated resistance in canine osteosarcoma (COS31) cells.
Shoieb AM; Hahn KA; Van Laack RL; Barnhill MA
In Vivo; 1998; 12(5):455-62. PubMed ID: 9827351
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes.
Gali-Muhtasib HU; Abou Kheir WG; Kheir LA; Darwiche N; Crooks PA
Anticancer Drugs; 2004 Apr; 15(4):389-99. PubMed ID: 15057144
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism.
Gali-Muhtasib H; Diab-Assaf M; Boltze C; Al-Hmaira J; Hartig R; Roessner A; Schneider-Stock R
Int J Oncol; 2004 Oct; 25(4):857-66. PubMed ID: 15375533
[TBL] [Abstract][Full Text] [Related]
7. NADPH quinone oxidoreductase 1 mediates breast cancer cell resistance to thymoquinone-induced apoptosis.
Sutton KM; Doucette CD; Hoskin DW
Biochem Biophys Res Commun; 2012 Sep; 426(3):421-6. PubMed ID: 22960073
[TBL] [Abstract][Full Text] [Related]
8. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
10. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells.
Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone enhanced the antitumor activity of cisplatin in human bladder cancer 5637 cells in vitro.
Khodadadi F; Khorashadizadeh M; Ghasemi F
Mol Biol Rep; 2023 Jul; 50(7):5767-5775. PubMed ID: 37219672
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
[TBL] [Abstract][Full Text] [Related]
14. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone Induces Apoptosis in B16-F10 Melanoma Cell Through Inhibition of p-STAT3 and Inhibits Tumor Growth in a Murine Intracerebral Melanoma Model.
Hatiboglu MA; Kocyigit A; Guler EM; Akdur K; Nalli A; Karatas E; Tuzgen S
World Neurosurg; 2018 Jun; 114():e182-e190. PubMed ID: 29510292
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive and therapeutic potentials of thymoquinone in HepG2 cells: mechanistic perspectives.
ElKhoely A; Hafez HF; Ashmawy AM; Badary O; Abdelaziz A; Mostafa A; Shouman SA
J Nat Med; 2015 Jul; 69(3):313-23. PubMed ID: 25796541
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D
J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo.
Xu D; Ma Y; Zhao B; Li S; Zhang Y; Pan S; Wu Y; Wang J; Wang D; Pan H; Liu L; Jiang H
Oncol Rep; 2014 May; 31(5):2063-70. PubMed ID: 24603952
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Anti-Neuroblastoma Activity of Thymoquinone Against Neuro-2a Cells via Cell-cycle Arrest.
Paramasivam A; Raghunandhakumar S; Priyadharsini JV; Jayaraman G
Asian Pac J Cancer Prev; 2015; 16(18):8313-9. PubMed ID: 26745078
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone Augments Cisplatin-Induced Apoptosis on Esophageal Carcinoma Through Mitigating the Activation of JAK2/STAT3 Pathway.
Hu X; Ma J; Vikash V; Li J; Wu D; Liu Y; Zhang J; Dong W
Dig Dis Sci; 2018 Jan; 63(1):126-134. PubMed ID: 29197940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
